A comprehensive view of Vaccination / Immunization. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AstraZeneca to triple its R&D investment in China, hire over 900 R&D personnel in the country; AstraZeneca to offer at least 15 new drugs in Chinese market by 2030, including oncology, respiratory disease, immunization, vaccines, rare disease drugs

Moderna CEO defends company’s plans to hike cost of its COVID-19 vaccine from less than US$30 per dose to US$130 per dose later this year in Senate hearing; senators criticized the move, noting US invested nearly US$2.0B to develop the vaccine

BioNTech Q4 profit down at €2.28B from €3.17B a year ago on weak revenues of €4.28B; sees FY23 COVID-19 vaccine revenues of €5.0B

BioNTech Announces Fourth Quarter and Full Year 2022 Financial Results and Corporate Update

Moderna to host fourth annual Virtual Vaccines Day on April 11, 2023 at 8 a.m. ET for analysts and investors; Vaccines Day will include presentations from management and opinion leaders on Moderna's mRNA vaccines and considerations for vaccine development

Ask us about our Consumer Wellness market view

Trending Chart

Interactive chart with headline count